Teddy Amenabar of The Washington Post reports on a Stanford study suggesting that a ketogenic diet could improve symptoms in schizophrenia and bipolar disorder, while reducing medication side effects. Further research is needed to confirm these findings.

A Stanford study suggests that a ketogenic diet could improve both metabolic and psychiatric symptoms in patients with schizophrenia and bipolar disorder. Despite a small sample size, the findings highlight the potential role of diet in managing serious mental illnesses.

Catherine Ho of the San Francisco Chronicle reports on a Stanford study suggesting that a ketogenic diet may improve psychiatric and metabolic symptoms in individuals with bipolar disorder and schizophrenia. The research, led by Dr. Shebani Sethi, highlights the potential of high-fat, low-carb diets in managing serious mental illnesses.

A Stanford Medicine pilot study suggests that a ketogenic diet may improve both metabolic and psychiatric symptoms in patients with schizophrenia and bipolar disorder. Led by Dr. Shebani Sethi, the study found significant improvements in mental health and metabolic conditions, offering a potential new approach to treating serious mental illnesses.

Shebani Sethi, MD, associate professor of psychiatry and behavioral sciences at Stanford Medicine, shares the results of a pilot study showing that a ketogenic diet can alleviate the symptoms of mental illnesses such as bipolar disorder and schizophrenia.

Dr. Shebani Sethi, a Stanford psychiatrist, pioneers metabolic psychiatry, linking metabolic health to mental illness. Her research explores the ketogenic diet’s potential to treat conditions like bipolar disorder and schizophrenia, aiming to revolutionize mental health care by addressing underlying metabolic issues.

Dr. Shebani Sethi's study found that 69% of bipolar disorder patients improved significantly after a four-month ketogenic diet. The diet may help address metabolic deficits in the brain, showing a 31% average improvement in mental illness severity.

Dani Blum of the New York Times interviews Metabolic Psychiatry® expert, Dr. Shebani Sethi, on the importance of careful prescribing of weight loss drugs to counteract weight gain side effects from antidepressants and antipsychotics.

Dr. Shebani Sethi provides expert commentary for Good Morning America’s news segment on the thoughtful prescribing of Ozempic and related medications to address weight gain after psychiatric care.

Dr. Sethi writes about how nutrition contributes to overall health.

Dr. Sethi discusses how the practice of medicine has changed in the age of telehealth

San Francisco Times comments on a Metabolic Psychiatry® study in bipolar disorder led by Dr. Sethi.

Dr. Sethi answers popular questions about metabolism and mental health

Dr. Sethi defines Metabolic Psychiatry

Interviewed by Silvia Segerstrale at Stanford Concierge Medicine, both Dr. Shebani Sethi , and Dr. Lucia Aronica discuss ketogenic diets and intermittent fasting.

Dr. Shebani Sethi, is an interviewed guest on the top 10 health apple podcast The Doctor’s Farmacy about how ultra-processed foods affects mental health and on metabolic psychiatry - which focuses on treatment of metabolic dysfunction and investigates the influences of nutrition, inflammation, and insulin resistance on psychiatric outcomes.

Anika Sinha writes about the link between nutrition, blood sugar, and immunity during COVID-19 in the Stanford Daily. She interviews both a Stanford infectious disease expert and the director of metabolic psychiatry at Stanford to explain the link to mental health.

Stanford Medicine scientists have linked insulin resistance to an increased risk of developing major depressive disorder, study lead author Dr. Katie Watson indicates. About 1 in 3 American adults has insulin resistance, a silent time bomb that doubles their risk for serious depression, per Dr. Natalie Rasgon.